Patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastroparesis, active pancreatitis, or who are pregnant or planning pregnancy are generally not candidates for GLP-1 therapy
The research results demonstrated that saponins with clear anti-tumor effects mostly have cytotoxicity and can exert significant anti-cancer effects by inhibiting cancer cell proliferation, inducing cell apoptosis, inhibiting cell migration, and inducing cell cycle arrest
Lastly, in treating other diseases, modulating NRF2 deubiquitination in skin macrophages affects pain perception[126] (Table 4)
Transdermal estrogen also carries additional benefits independent of GLP-1 compatibility
No GP or specialist in the UK would be in a position to supervise or endorse the combined use of these two agents outside of a formal clinical trial, given the complete absence of safety and efficacy data for this combination
Compounded medications cannot legally make efficacy claims because they have not undergone the clinical trials necessary to support such claims
